| 13-Jan-2003 | S | Stock split of existing equity share from every one existing equity share of Rs.10/- each into ten equity shares of Re.1/- each.
Reduced paid-up value - Re.1/-
Reduced paid-up value w.e.f. - 03/02/2003.
| 11-Feb-2003 | |
| 13-May-2011 | D | Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2011, inter alia, has recommended dividend of Re. 0.75 (75%) each on Equity Shares of the Company, for the financial year 2010-11. The total amount of dividend payable, if approved by Shareholders in their ensuing Annual General Meeting, shall be Rs. 45.9 million, excluding dividend distribution tax. | 19-Sep-2011 | |
| 07-May-2010 | D | Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2010, inter alia, has recommended dividend of Re. 0.25 (25%) each on Equity Shares of the Company, for the financial year 2009-10. The total amount of dividend payable, if approved by Shareholders, shall be Rs. 16.7 million, excluding dividend distribution tax. | 16-Sep-2010 | |
| 26-Jun-2008 | D | Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 26, 2008, inter alia, has recommended dividend @ 100% (i.e. Re 1/- per share) on Equity Shares of the Company, for the financial year 2007-08. | 19-Sep-2008 | |
| 14-Jun-2007 | D | 100% Dividend | 21-Sep-2007 | |
| 12-Aug-2005 | D | 150% Dividend | 12-Aug-2005 | |
| 13-Nov-2024 | BC | The Board of Directors of Panacea Biotec Limited has, at its meeting held today, 13.11.2024, inter-alia, considered and approved:
1. Re-appointment of Dr. Rajesh Jain as Chairman and Managing Direc | 01-Jan-2025 | |
| 26-Nov-2024 | BC | Please find attached a copy of the Postal Ballot Notice dated November 13 2024 along with Annexure thereto being sent to the shareholders through email only for the purpose of obtaining their approva | 26-Dec-2024 | |
| 30-Oct-2024 | BC | PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Standalone and Consolidated Unaudited Finan | 13-Nov-2024 | |
| 12-Nov-2024 | BC | appointment of Mr. Rajesh Jain (DIN: 10619014) as an additional director in the capacity of Non-executive Independent Director for a period of 5 (five) years from November 12, 2024, subject to approv | 13-Nov-2024 | |
| 12-Nov-2024 | BC | The Board of Directors of the Company''s unlisted material subsidiary, Panacea Biotec Pharma Ltd. has in its meeting held today i.e. 12.11.2024, inter-alia, approved the following: 1. Appointment of | 12-Nov-2024 | |
Announcement Date13-May-2011
Ex Dividend Date19-Sep-2011
Dividend(%)75
Announcement Date07-May-2010
Ex Dividend Date16-Sep-2010
Dividend(%)25
Announcement Date26-Jun-2008
Ex Dividend Date19-Sep-2008
Dividend(%)100
Announcement Date14-Jun-2007
Ex Dividend Date21-Sep-2007
Dividend(%)100
Announcement Date12-Aug-2005
Ex Dividend Date12-Aug-2005
Dividend(%)150
No Bonus has been declared by PANACEABIO
Record Date11-Feb-2003
Split Date03-Feb-2003
Face Value (Before/After)10/1
RightsNo Rights has been declared by PANACEABIO
Book Closure
| 01-Jan-2025 | - | The Board of Directors of Panacea Biotec Limited has, at its meeting held today, 13.11.2024, inter-alia, considered and approved:
1. Re-appointment of Dr. Rajesh Jain as Chairman and Managing Direc |
| 26-Dec-2024 | 01 Jan'1900 | Please find attached a copy of the Postal Ballot Notice dated November 13 2024 along with Annexure thereto being sent to the shareholders through email only for the purpose of obtaining their approva |
| 13-Nov-2024 | - | PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Standalone and Consolidated Unaudited Finan |
| 13-Nov-2024 | - | appointment of Mr. Rajesh Jain (DIN: 10619014) as an additional director in the capacity of Non-executive Independent Director for a period of 5 (five) years from November 12, 2024, subject to approv |
| 12-Nov-2024 | - | The Board of Directors of the Company''s unlisted material subsidiary, Panacea Biotec Pharma Ltd. has in its meeting held today i.e. 12.11.2024, inter-alia, approved the following: 1. Appointment of |